Form 4 for NEPH NEPHROS INC
Accepted 2026-03-25 00:00:00 ET · period of report 2026-03-23 · accession 0000914190-26-000052 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-03-25 | 2026-03-23 | NEPH | Krandel Judy | CFO | M - OptEx | $1.71 | +68.9K | 68.9K | New | +$117.8K |
| D | 2026-03-25 | 2026-03-23 | NEPH | Krandel Judy | CFO | M - OptEx | $0.00 | -68.9K | 53.7K | -56% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-03-23 | M | A | 68,861 | $1.71 | 68,861 | D | — | — | |
| 2 | Derivative | Stock Option (right to buy) | 2026-03-23 | M | D | 68,861 | $0.00 | 53,663 | D | $1.71 · — to 2033-11-01 | 68,861 Common Stock | (F1) Options to purchase 30,631 shares vest on 11/1/2024 and options to purchase the remaining 91,893 shares vest quarterly in 12 equal amounts commencing on 2/1/2025. |